Development and characterization of injectable alginate/sericin/chondroitin sulphate microspheres for cartilage tissue engineering /

Göl, Nil
Osteoarthritis (OA) is one of the joint diseases with the highest prevalence worldwide. Eighty percent of the OA patients present limitation in joint movements and 25% cannot perform their daily activities. Due to loss of regenerative potency in OA joints, treatments with drugs and bioactive agents can provide only limited recovery in the damaged cartilage tissue. Current studies and clinical approaches therefore, mostly focus on cell based treatments with hydrogel carriers. The microcarrier systems supply an efficient method of delivery of cells and drugs within non-invasive, injectable systems. The aim of this thesis was to develop and optimize Cartilage Cell containing injectable Alginate/Sericin/Chondroitin sulphate microspheres (ALG/SER/CS) to modify the natural course of OA. In this study Alginate (ALG), sericin and Chondroitin sulphate materials were mixed at specific concentrations and ALG/SER/CS microspheres with average size of 192±46 µm were prepared by Electrospraying method. Due to high water uptake and less aqueous stability these microspheres needed to be further modified with silk fibroin (SF) using two methods; incorporation and coating. vi The degradation analyses showed that ALG/SER/CS microspheres with SF showed a slow degradation profile in two weeks. During this period, slow, sustained release of Sericin and CS were achieved. By this approach it is thought that CS will be released continuously and as a component of native cartilage tissue ECM, it will enhance regeneration. Released sericin will provide a protein surface for attachment and proliferation of cartilage cells. The cell culture studies were done with the cartilage cell line and the microspheres were shown to increase the cell attachment and proliferation. According to these results, it can be suggested that the developed microcarriers can be for used as injectable systems and have potential for application for Osteoarthritis (OA). In vivo studies on the developed cell microcarriers should be done in further studies to confirm the usability of the microsystems.


Evaluation of effectiveness of different bioactive agents for treatment of osteoarthritis with in vitro model under dynamic mechanical stimulation
Kavas, Ayşegül; Tezcaner, Ayşen; Department of Engineering Sciences (2007)
Osteoarthritis (OA) is a disease characterized by the progressive degradation of articular cartilage. Current strategies for the disease are mainly towards relieving symptoms. This study was aimed to investigate the therapeutic potentials of Bone Morphogenetic Protein-9 (BMP-9), Raloxifene (Ral) and Pluronic F-68 (PLF-68) with a three-dimensional in vitro OA model. Articular chondrocytes isolated from rats were cultured in growth media and embedded in agarose to obtain agarose-chondrocyte discs. Dynamic hyd...
Investigation of on skin surface response due to acoustic radiation from stenosed blood vessels
Salman, Huseyin E.; Yazıcıoğlu, Yiğit (2015-11-02)
Arterial stenosis is a form of cardiovascular disease which leads to highest rate of fatalities worldwide. When stenosis is present in coronary arteries, it leads to heart attack and often sudden death. Arterial disease is usually not confined to critical organs such as the heart and the brain but observed throughout the peripheral cardiovascular system. When an artery has a diameter reduction, acoustic radiation originating from this constriction propagates through soft tissues and reaches to skin surface....
In vitro and in vivo evaluation of doxycycline-chondroitin sulfate/PCLmicrospheres for intraarticular treatment of osteoarthritis
AYDIN, Ozlem; KORKUSUZ, FEZA; KORKUSUZ, PETEK; Tezcaner, Ayşen; BİLGİÇ, ELİF; Yaprakci, Volkan; Keskin, Dilek (2015-08-01)
Osteoarthritis (OA) is a degenerative joint disease, which has no complete treatment with medication yet. Intraarticular hyaluronan (HA) injection can decrease pain and modify the natural course of OA. This study was designed to provide long term delivery of an MMP (matrix-metalloproteinase) inhibitor agent-doxycycline, together with matrix regenerative agent-chondroitin sulfate for treating OA which progress with matrix degenerations. Doxycycline (D) and doxycycline-chondroitin sulfate (D-CS) loaded poly--...
Investigation of fluid structure interaction in cardiovascular system from diagnostic and pathological perspective
Salman, Hüseyin Enes; Yazıcıoğlu, Yiğit; Sert, Cüneyt; Department of Mechanical Engineering (2012)
Atherosclerosis is a disease of the cardiovascular system where a stenosis may develop in an artery which is an abnormal narrowing in the blood vessel that adversely affects the blood flow. Due to the constriction of the blood vessel, the flow is disturbed, forming a jet and recirculation downstream of the stenosis. Dynamic pressure fluctuations on the inner wall of the blood vessel leads to the vibration of the vessel structure and acoustic energy is propagated through the surrounding tissue that can be de...
Evaluation and discrimination of simvastatin-induced structural alterations in proteins of different rat tissues by FTIR spectroscopy and neural network analysis
Garip, Sebnem; Yapici, Engin; Ozek, Nihal Simsek; Severcan, Mete; Severcan, Feride (Royal Society of Chemistry (RSC), 2010-01-01)
Statins are commonly used to control hypercholesterolemia and to prevent cardiovascular diseases. Among the statins, Simvastatin is one of the most frequently prescribed statins because of its efficacy in reducing LDL lipoprotein cholesterol levels, its tolerability, and its reduction of cardiovascular risk and mortality. Conflicting results have been reported with regard to benefits (pleiotropic effects) as well as risks (adverse effects) of simvastatin on different soft and hard tissues. In the current st...
Citation Formats
N. Göl, “Development and characterization of injectable alginate/sericin/chondroitin sulphate microspheres for cartilage tissue engineering /,” M.S. - Master of Science, Middle East Technical University, 2015.